Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 33,524 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 33,524 shares of the company’s stock in a transaction on Friday, April 11th. The stock was purchased at an average price of $0.69 per share, with a total value of $23,131.56. Following the completion of the transaction, the chief executive officer now owns 15,201,112 shares of the company’s stock, valued at approximately $10,488,767.28. This trade represents a 0.22 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Retractable Technologies Stock Up 3.1 %

NYSE RVP opened at $0.70 on Tuesday. Retractable Technologies, Inc. has a 12 month low of $0.56 and a 12 month high of $1.22. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock has a market cap of $20.99 million, a PE ratio of -1.30 and a beta of 2.28. The stock’s 50 day moving average is $0.75 and its 200 day moving average is $0.73.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on Retractable Technologies in a research note on Saturday. They issued a “hold” rating for the company.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC purchased a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned about 8.46% of Retractable Technologies as of its most recent filing with the SEC. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.